1. Anti-angiogenesis maintenance therapy in newly diagnosed and relapsed ovarian cancer: a meta-analysis of phase III randomized controlled trials;Y Z Wang;Front. Pharmacol,2021
2. Clinical significance of screening differential metabolites in ovarian cancer tissue and ascites by LC/MS;M Liu;Front. Pharmacol,2021
3. Identifying the effect of celastrol against ovarian cancer with network pharmacology and in vitro experiments;X Wang;Front. Pharmacol,2022
4. Epithelial ovarian cancer and the immune system: biology, interactions, challenges and potential advances for immunotherapy;A M Macpherson;J. Clin. Med,2020
5. A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer;L Falzone;Int. J. Oncol,2021